GNMK Share Price

Open 8.03 Change Price %
High 8.06 1 Day -0.22 -2.73
Low 7.68 1 Week -1.05 -11.81
Close 7.84 1 Month -1.72 -17.99
Volume 331377 1 Year -4.23 -35.05
52 Week High 13.67
52 Week Low 7.68
GNMK Important Levels
Resistance 2 8.19
Resistance 1 8.05
Pivot 7.86
Support 1 7.63
Support 2 7.49
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
ASTI 0.00 0.00%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
DCTH 0.04 33.33%
RITT 0.04 33.33%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
NEXS 0.05 25.00%
PRAN 3.25 24.52%
PGRX 0.06 20.00%
More..
NASDAQ USA Top Losers Stocks
CAFI 0.00 -100.00%
LIWA 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
More..

GenMark Diagnostics, Inc. (NASDAQ: GNMK)

GNMK Technical Analysis 5
As on 19th Oct 2017 GNMK Share Price closed @ 7.84 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 11.59 & Strong Sell for SHORT-TERM with Stoploss of 9.54 we also expect STOCK to react on Following IMPORTANT LEVELS.
GNMK Target for October
1st Target up-side 10.23
2nd Target up-side 10.66
3rd Target up-side 11.08
1st Target down-side 9.03
2nd Target down-side 8.6
3rd Target down-side 8.18
GNMK Other Details
Segment EQ
Market Capital 273291424.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.genmarkdx.com
GNMK Address
GNMK
5964 La Place Court
Carlsbad, CA 92008
United States
Phone: 760-448-4300
Fax: 760-448-4301
GNMK Latest News
Interactive Technical Analysis Chart GenMark Diagnostics, Inc. ( GNMK NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on GenMark Diagnostics, Inc.
GNMK Business Profile
GenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company focused on developing and commercializing its eSensor detection technology. The Company�s electrochemical technology enables detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA), and is designed to support a range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges. Within 30 minutes of receipt of an amplified deoxyribonucleic acid (DNA) sample, its XT-8 System produces results. The XT-8 System supports up to 24 test cartridges, which can be run independently, and are targeted for hospitals and reference laboratories. The Company is also developing its next-generation platform, the AD-8 System, to integrate DNA amplification with its eSensor detection technology to enable technicians to place a minimally prepared patient sample into its test cartridge.